Evidence map›Paper›PMID 26120530›Full record

ArticleAllergo journal international

S3-Guideline on allergy prevention: 2014 update: Guideline of the German Society for Allergology and Clinical Immunology (DGAKI) and the German Society for Pediatric and Adolescent Medicine (DGKJ).

Torsten Schäfer, Carl-Peter Bauer, Kirsten Beyer, Albrecht Bufe, Frank Friedrichs, Uwe Gieler, Gerald Gronke, Eckard Hamelmann, Mechthild Hellermann, Andreas Kleinheinz and 16 more

Abstract read
In one paragraph

Article in Allergo journal international. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Dietary factors during pregnancy and atopic outcomes in childhood: A systematic review from the European Academy of Allergy and Clinical Immunology.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2020
    Pooled it
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Treatment of Allergies to Fur Animals.International journal of molecular sciences · 2024
    Review
  9. Health Literacy in Pediatric Consultations on Allergy Prevention.Health literacy research and practice · 2024
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Torsten SchäferKirchplatz 3, 87509 Immenstadt, Germany.
Carl-Peter BauerGaißach Specialist Clinic, Berlin, Germany.
Kirsten BeyerCharité Allergy Center, Clinic for Pediatrics with Special Focus on Pneumology and Immunology, Charité University Hospital, Berlin, Germany.
Albrecht BufeDepartment of Experimental Pneumology, Ruhr University Bochum, Bochum, Germany.
Frank FriedrichsLaurensberg, Germany.
Uwe GielerDermatological Clinic, Gießen and Marburg University Clinic, Gießen site, Gießen, Germany.
Gerald GronkeBlankenfelde, Germany.
Eckard HamelmannClinic for Pediatric Medicine, Ruhr University Bochum, Bochum, Germany.
Mechthild HellermannTherapie Schwelmer Modell GmbH, Schwelm, Germany.
Andreas KleinheinzDermatological Center, Elbe Clinics Stade/Buxtehude, Buxtehude, Germany.
Ludger KlimekCenter for Rhinology and Allergology, Wiesbaden, Germany.
Sibylle KoletzkoDr. von Haunersches Children's Hospital, Pediatric Clinic and Pediatric Polyclinic of the Ludwig Maximilian University, Munich, Germany.
Matthias KoppClinic for Pediatric Medicine, Schleswig-Holstein University Clinic, Lübeck Campus, Lübeck, Germany.
Susanne LauCharité Allergy Center, Clinic for Pediatrics with Special Focus on Pneumology and Immunology, Charité University Hospital, Berlin, Germany.
Horst MüskenBad Lippspringe, Germany.
Imke ReeseNutrition Counseling and Therapy with Special Focus on Allergology, Munich, Germany.
Sabine SchmidtKinderumwelt GmbH, Osnabruck, Germany.
Sabine SchnadtGerman Allergy and Asthma Association, Monchengladbach, Germany.
Helmut SitterInstitute for Theoretical Surgery, Marburg University, Marburg, Germany.
Klaus StrömerProfessional Association of German Dermatologists, Mönchengladbach, Germany.
Jennifer VagtsDermatological Center, Elbe Clinics Stade/Buxtehude, Buxtehude, Germany.
Christian VogelbergClinic and Polyclinic for Pediatric Medicine, Carl Gustav Carus University Clinic, Dresden, Germany.
Ulrich WahnCharité Allergy Center, Clinic for Pediatrics with Special Focus on Pneumology and Immunology, Charité University Hospital, Berlin, Germany.
Thomas WerfelClinic and Polyclinic for Dermatology and Venereology, Hannover Medical School, Hannover, Germany.
Margitta WormCharité Allergy Center, Clinic for Dermatology, Venereology, and Allergology, Charité University Hospital, Charité Campus Mitte, Berlin, Germany.
Cathleen Muche-BorowskiGerman Association of the Scientific Medical Societies, Marburg, Germany ; Institute for General Medicine, Hamburg-Eppendorf University Clinic, Germany, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The continued high prevalence of allergic diseases in Western industrialized nations combined with the limited options for causal therapy make evidence-based primary prevention necessary. The recommendations last published in the S3-guideline on allergy prevention in 2009 have been revised and a consensus reached on the basis of an up-to-date systematic literature search. Evidence was sought for the period between May 2008 and May 2013 in the Cochrane and MEDLINE electronic databases, as well as in the reference lists of recent review articles. In addition, experts were surveyed for their opinions. The relevance of retrieved literature was checked by means of two filter processes: firstly according to title and abstract, and secondly based on the full text of the articles. Included studies were given an evidence grade, and a bias potential (low/high) was specified for study quality. A formal consensus on the revised recommendations was reached by representatives of the relevant specialist societies and (self-help) organizations (nominal group process). Of 3,284 hits, 165 studies (one meta-analysis, 15 systematic reviews, 31 randomized controlled trials, 65 cohort studies, 12 case-control studies and 41 cross-sectional studies) were included and evaluated. Recommendations on the following remain largely unaltered: full breastfeeding for 4 months as a means of allergy prevention (hypoallergenic infant formula in the case of infants at risk); avoidance of overweight; fish consumption (during pregnancy/lactation and in the introduction of solid foods for infants); vaccination according to the recommendations of the German Standing Committee on Vaccination (Ständige Impfkommission, STIKO); avoidance of air pollutants and tobacco exposure and avoidance of indoor conditions conducive to the development of mold. The assertion that a reduction in house-dust mite allergen content as a primary preventive measure is not recommended also remains unchanged. The introduction of solid foods into infant diet should not be delayed. In the case of children at risk cats should not be acquired as domestic pets. Keeping dogs is not associated with an increased risk of allergy. The updated guideline includes a new recommendation to consider the increased risk of asthma following delivery by cesarean section. Additional statements have been formulated on pre- and probiotic agents, psychosocial factors, medications, and various nutritional components. Revising the guideline by using an extensive evidence base has resulted not only in an endorsement of the existing recommendations, but also in modifications and in the addition of new recommendations. The updated guideline enables evidence-based and up-to-date recommendations to be made on allergy prevention. ELECTRONIC SUPPLEMENTARY MATERIAL: Supplementary material is available for this article at 10.1007/s40629-014-0022-4 and is accessible for authorized users.

Indexed as

Allergyevidenceprimary preventionrevisionS3-guidelines

Identifiers

PMID26120530
PMCPMC4479452

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.